C5 and Stargardt disease: Avacincaptad Pegol: Avacincaptad pegol binds to and inhibits the C5 protein, and is administered every month as a treatment for complement-mediated eye diseases, such as age-related macular degeneration and Stargardt macular dystrophy [58,91].